Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
BACKGROUND: Artesunate plus sulphadoxine-pyrimethamine (AS+SP) is now first-line treatment for Plasmodium falciparum infection in several south Asian countries, including Afghanistan. Molecular studies provide a sensitive means to investigate the current state of drug susceptibility to the SP compon...
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Journal article |
| 語言: | English |
| 出版: |
BioMed Central
2013
|